Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment

Saved in:
Bibliographic Details
Published in:Leukemia & lymphoma 2016-10, Vol.57 (10), p.2425-2428
Main Authors: Amorim, Sandy, Fleury, Isabelle, Mounier, Nicolas, Harel, Stéphanie, Brice, Pauline, Thieblemont, Catherine
Format: Article
Language:English
Subjects:
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Chemotherapy, Adjuvant
Combined Modality Therapy
Consolidation Chemotherapy - methods
Drug Resistance, Neoplasm - drug effects
Etoposide - administration & dosage
Etoposide - adverse effects
Female
Humans
Ifosfamide - administration & dosage
Ifosfamide - adverse effects
Lymphoma, Large B-Cell, Diffuse - mortality
Lymphoma, Large B-Cell, Diffuse - pathology
Lymphoma, Large B-Cell, Diffuse - therapy
Male
Middle Aged
Mitoxantrone - administration & dosage
Mitoxantrone - adverse effects
Recurrence
Retrospective Studies
Rituximab - administration & dosage
Stem Cell Transplantation - methods
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c314t-3ee728dd486e818c819f8f9f15411bc6130247a8e62c0d115d1ac4d1aa93d9733
container_end_page 2428
container_issue 10
container_start_page 2425
container_title Leukemia & lymphoma
container_volume 57
creator Amorim, Sandy
Fleury, Isabelle
Mounier, Nicolas
Harel, Stéphanie
Brice, Pauline
Thieblemont, Catherine
description
doi_str_mv 10.3109/10428194.2015.1135437
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808375450</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1808375450</sourcerecordid><originalsourceid>FETCH-LOGICAL-c314t-3ee728dd486e818c819f8f9f15411bc6130247a8e62c0d115d1ac4d1aa93d9733</originalsourceid><addsrcrecordid>eNp9Uctu1DAUjRCIlsIngLxkQQZf23ntoKMWkCqxgXXkia87Rn4E21E7H8k_4cxMWbLxvZbPwzqnqt4C3XCgw0eggvUwiA2j0GwAeCN496y6BMqGmgnKn6-7YPUKuqhepfSLUtoMLXtZXbC2a2gr-GX1Zxt8CtYomU3wJO8xyvlAHkzeE2dyeJQ-x-DxAzE6JC2dUUikVwRzmENab0dsiMcZlkyiycujcXJHdqhDRJIyOjKhtSRH6dNsi-bJzngS0co5oSLKaL0kJFbGeyTX9ZFgD27eByfJXAjocyJaGmv8PUk4Ba_qsmORRZldeX5dvdDSJnxznlfVz9ubH9uv9d33L9-2n-_qiYPINUfsWK-U6FvsoZ9KRLrXg4ZGAOymFjhlopM9tmyiCqBRICdRDjlwNXScX1XvT7pzDL8XTHl0Jq0flh7Dkkboac-7RjS0QJsTdIohpYh6nGMJJx5GoOPa5PjU5Lg2OZ6bLLx3Z4tl51D9Yz1VVwCfTgDjS8pOPoRo1ZjlwYaoS86TSav-_zz-AiR4s4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1808375450</pqid></control><display><type>article</type><title>Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Amorim, Sandy ; Fleury, Isabelle ; Mounier, Nicolas ; Harel, Stéphanie ; Brice, Pauline ; Thieblemont, Catherine</creator><creatorcontrib>Amorim, Sandy ; Fleury, Isabelle ; Mounier, Nicolas ; Harel, Stéphanie ; Brice, Pauline ; Thieblemont, Catherine</creatorcontrib><identifier>ISSN: 1042-8194</identifier><identifier>EISSN: 1029-2403</identifier><identifier>DOI: 10.3109/10428194.2015.1135437</identifier><identifier>PMID: 26750643</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Chemotherapy, Adjuvant ; Combined Modality Therapy ; Consolidation Chemotherapy - methods ; Drug Resistance, Neoplasm - drug effects ; Etoposide - administration &amp; dosage ; Etoposide - adverse effects ; Female ; Humans ; Ifosfamide - administration &amp; dosage ; Ifosfamide - adverse effects ; Lymphoma, Large B-Cell, Diffuse - mortality ; Lymphoma, Large B-Cell, Diffuse - pathology ; Lymphoma, Large B-Cell, Diffuse - therapy ; Male ; Middle Aged ; Mitoxantrone - administration &amp; dosage ; Mitoxantrone - adverse effects ; Recurrence ; Retrospective Studies ; Rituximab - administration &amp; dosage ; Stem Cell Transplantation - methods ; Treatment Outcome</subject><ispartof>Leukemia &amp; lymphoma, 2016-10, Vol.57 (10), p.2425-2428</ispartof><rights>2016 Informa UK Limited, trading as Taylor &amp; Francis Group 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c314t-3ee728dd486e818c819f8f9f15411bc6130247a8e62c0d115d1ac4d1aa93d9733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26750643$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Amorim, Sandy</creatorcontrib><creatorcontrib>Fleury, Isabelle</creatorcontrib><creatorcontrib>Mounier, Nicolas</creatorcontrib><creatorcontrib>Harel, Stéphanie</creatorcontrib><creatorcontrib>Brice, Pauline</creatorcontrib><creatorcontrib>Thieblemont, Catherine</creatorcontrib><title>Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment</title><title>Leukemia &amp; lymphoma</title><addtitle>Leuk Lymphoma</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Chemotherapy, Adjuvant</subject><subject>Combined Modality Therapy</subject><subject>Consolidation Chemotherapy - methods</subject><subject>Drug Resistance, Neoplasm - drug effects</subject><subject>Etoposide - administration &amp; dosage</subject><subject>Etoposide - adverse effects</subject><subject>Female</subject><subject>Humans</subject><subject>Ifosfamide - administration &amp; dosage</subject><subject>Ifosfamide - adverse effects</subject><subject>Lymphoma, Large B-Cell, Diffuse - mortality</subject><subject>Lymphoma, Large B-Cell, Diffuse - pathology</subject><subject>Lymphoma, Large B-Cell, Diffuse - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mitoxantrone - administration &amp; dosage</subject><subject>Mitoxantrone - adverse effects</subject><subject>Recurrence</subject><subject>Retrospective Studies</subject><subject>Rituximab - administration &amp; dosage</subject><subject>Stem Cell Transplantation - methods</subject><subject>Treatment Outcome</subject><issn>1042-8194</issn><issn>1029-2403</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9Uctu1DAUjRCIlsIngLxkQQZf23ntoKMWkCqxgXXkia87Rn4E21E7H8k_4cxMWbLxvZbPwzqnqt4C3XCgw0eggvUwiA2j0GwAeCN496y6BMqGmgnKn6-7YPUKuqhepfSLUtoMLXtZXbC2a2gr-GX1Zxt8CtYomU3wJO8xyvlAHkzeE2dyeJQ-x-DxAzE6JC2dUUikVwRzmENab0dsiMcZlkyiycujcXJHdqhDRJIyOjKhtSRH6dNsi-bJzngS0co5oSLKaL0kJFbGeyTX9ZFgD27eByfJXAjocyJaGmv8PUk4Ba_qsmORRZldeX5dvdDSJnxznlfVz9ubH9uv9d33L9-2n-_qiYPINUfsWK-U6FvsoZ9KRLrXg4ZGAOymFjhlopM9tmyiCqBRICdRDjlwNXScX1XvT7pzDL8XTHl0Jq0flh7Dkkboac-7RjS0QJsTdIohpYh6nGMJJx5GoOPa5PjU5Lg2OZ6bLLx3Z4tl51D9Yz1VVwCfTgDjS8pOPoRo1ZjlwYaoS86TSav-_zz-AiR4s4A</recordid><startdate>20161002</startdate><enddate>20161002</enddate><creator>Amorim, Sandy</creator><creator>Fleury, Isabelle</creator><creator>Mounier, Nicolas</creator><creator>Harel, Stéphanie</creator><creator>Brice, Pauline</creator><creator>Thieblemont, Catherine</creator><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20161002</creationdate><title>Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment</title><author>Amorim, Sandy ; Fleury, Isabelle ; Mounier, Nicolas ; Harel, Stéphanie ; Brice, Pauline ; Thieblemont, Catherine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c314t-3ee728dd486e818c819f8f9f15411bc6130247a8e62c0d115d1ac4d1aa93d9733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Chemotherapy, Adjuvant</topic><topic>Combined Modality Therapy</topic><topic>Consolidation Chemotherapy - methods</topic><topic>Drug Resistance, Neoplasm - drug effects</topic><topic>Etoposide - administration &amp; dosage</topic><topic>Etoposide - adverse effects</topic><topic>Female</topic><topic>Humans</topic><topic>Ifosfamide - administration &amp; dosage</topic><topic>Ifosfamide - adverse effects</topic><topic>Lymphoma, Large B-Cell, Diffuse - mortality</topic><topic>Lymphoma, Large B-Cell, Diffuse - pathology</topic><topic>Lymphoma, Large B-Cell, Diffuse - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mitoxantrone - administration &amp; dosage</topic><topic>Mitoxantrone - adverse effects</topic><topic>Recurrence</topic><topic>Retrospective Studies</topic><topic>Rituximab - administration &amp; dosage</topic><topic>Stem Cell Transplantation - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Amorim, Sandy</creatorcontrib><creatorcontrib>Fleury, Isabelle</creatorcontrib><creatorcontrib>Mounier, Nicolas</creatorcontrib><creatorcontrib>Harel, Stéphanie</creatorcontrib><creatorcontrib>Brice, Pauline</creatorcontrib><creatorcontrib>Thieblemont, Catherine</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Leukemia &amp; lymphoma</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Amorim, Sandy</au><au>Fleury, Isabelle</au><au>Mounier, Nicolas</au><au>Harel, Stéphanie</au><au>Brice, Pauline</au><au>Thieblemont, Catherine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment</atitle><jtitle>Leukemia &amp; lymphoma</jtitle><addtitle>Leuk Lymphoma</addtitle><date>2016-10-02</date><risdate>2016</risdate><volume>57</volume><issue>10</issue><spage>2425</spage><epage>2428</epage><pages>2425-2428</pages><issn>1042-8194</issn><eissn>1029-2403</eissn><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>26750643</pmid><doi>10.3109/10428194.2015.1135437</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1042-8194
ispartof Leukemia & lymphoma, 2016-10, Vol.57 (10), p.2425-2428
issn 1042-8194
1029-2403
language eng
recordid cdi_proquest_miscellaneous_1808375450
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Adult
Aged
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Chemotherapy, Adjuvant
Combined Modality Therapy
Consolidation Chemotherapy - methods
Drug Resistance, Neoplasm - drug effects
Etoposide - administration & dosage
Etoposide - adverse effects
Female
Humans
Ifosfamide - administration & dosage
Ifosfamide - adverse effects
Lymphoma, Large B-Cell, Diffuse - mortality
Lymphoma, Large B-Cell, Diffuse - pathology
Lymphoma, Large B-Cell, Diffuse - therapy
Male
Middle Aged
Mitoxantrone - administration & dosage
Mitoxantrone - adverse effects
Recurrence
Retrospective Studies
Rituximab - administration & dosage
Stem Cell Transplantation - methods
Treatment Outcome
title Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T17%3A04%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Consolidation%20therapy%20with%20mitoxantrone,%20ifosfamide%20and%20etoposide%20with%20or%20without%20rituximab%20before%20stem%20cell%20transplantation%20in%20relapsed%20diffuse%20large%20B-cell%20lymphoma%20patients%20failing%20second-line%20treatment&rft.jtitle=Leukemia%20&%20lymphoma&rft.au=Amorim,%20Sandy&rft.date=2016-10-02&rft.volume=57&rft.issue=10&rft.spage=2425&rft.epage=2428&rft.pages=2425-2428&rft.issn=1042-8194&rft.eissn=1029-2403&rft_id=info:doi/10.3109/10428194.2015.1135437&rft_dat=%3Cproquest_pubme%3E1808375450%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c314t-3ee728dd486e818c819f8f9f15411bc6130247a8e62c0d115d1ac4d1aa93d9733%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1808375450&rft_id=info:pmid/26750643&rfr_iscdi=true